Boston News
Most Popular Boston Story
Sanofi trims staff at Genzyme R&D as it builds Boston hub
A year after closing on its $20 billion acquisition of Genzyme, the new powers that be at Sanofi ($SNY) have triggered a round of layoffs and relocations in the R&D wing of the business in Read more...
Latest Headlines
- February 1, 2012
- November 23, 2011
- September 28, 2011
- September 1, 2011
- April 13, 2011
- January 28, 2011
- December 14, 2009
- November 11, 2009
- September 4, 2009
- December 1, 2008
- October 3, 2008
- June 4, 2008
- April 18, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
